Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-18

Clinical Trial Update: Preventive Treatment of VETD in Patients With Multiple Myeloma Receiving Chemotherapy With Thalidomide or Lenalinomide.

View source ↗

Summary

A completed clinical trial evaluating preventive treatment for VETD in patients with multiple myeloma receiving thalidomide- or lenalidomide-containing chemothe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Revlimid (lenalidomide)
  • Thalomid (thalidomide)

Snippet

Sponsor: LEO Pharma | Conditions: Multiple Myeloma | Status: COMPLETED